Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact, Feasibility Acceptability and Cost Effectiveness of the RTS,S/AS01 Malaria Vaccine in School Aged Children

NCT06424002 is registered in ClinicalTrials.gov with Kamuzu University of Health Sciences as lead sponsor.

NCT NCT06424002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06424002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact, Feasibility Acceptability and Cost Effectiveness of the RTS,S/AS01 Malaria Vaccine in School Aged Children
Lead sponsor
Kamuzu University of Health Sciences
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2024
Completion date
December 30, 2024
Enrollment
5,400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malaria,falciparum